TELO2 inhibitors are a class of chemical compounds designed to selectively target and modulate the activity of the Telomere Maintenance 2 (TELO2) protein. TELO2 is a critical component of the Target of Rapamycin Complex 1 (TORC1), a multi-protein complex that plays a central role in regulating cell growth, metabolism, and response to nutrient availability. TORC1 is a key controller of cellular processes, including protein synthesis, autophagy, and ribosome biogenesis, which are essential for cell survival and growth. TELO2, as part of TORC1, contributes to the intricate signaling network that monitors cellular nutrient and energy status, allowing cells to adapt their growth and metabolic activities accordingly. TELO2 inhibitors are developed through chemical synthesis and structural optimization techniques, with the primary aim of interacting with specific domains or functional motifs of the TELO2 protein to influence its role in TORC1 signaling.
The design of TELO2 inhibitors typically involves creating molecules that can selectively bind to TELO2, potentially disrupting its interactions within the TORC1 complex or modulating its ability to relay cellular nutrient and energy status. By interfering with TELO2 activity, these inhibitors have the potential to affect the downstream signaling pathways regulated by TORC1, impacting cell growth and metabolic processes. The study of TELO2 inhibitors provides valuable insights into the intricate molecular mechanisms governing cell growth regulation and nutrient sensing, offering a deeper understanding of the fundamental processes that underlie cellular homeostasis and adaptation to changing environmental conditions. This research contributes to our knowledge of basic cell biology and the regulatory networks that control cell growth and metabolism.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor that can downregulate protein synthesis, potentially affecting TELO2 levels. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $88.00 $200.00 | 13 | |
A diterpene triepoxide that inhibits transcription by affecting RNA polymerase II activity, potentially reducing TELO2 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A pyrimidine analog that disrupts RNA processing and function, which could decrease TELO2 expression. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Interacts with DNA and prevents RNA synthesis, which could nonspecifically reduce TELO2 mRNA levels. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor that can impact multiple signaling pathways, potentially reducing TELO2 expression. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A kinase inhibitor with broad targets, possibly influencing transcription factors that regulate TELO2 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can alter gene expression patterns, possibly affecting TELO2 levels. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $51.00 $123.00 $178.00 | 11 | |
A cephalotaxine ester that inhibits protein translation, potentially decreasing TELO2 expression. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
Forms DNA adducts and may alter gene expression profiles, which could include TELO2. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $254.00 | 41 | |
A cyclin-dependent kinase inhibitor that can affect transcription and potentially reduce TELO2 expression. |